Superior diagnostic efficacy and cost advantage of FibroTouch over CHI3L1 for liver fibrosis in Chinese patients with chronic liver disease. Zuo Z, Yang C, Hu L, Ye X, et al. PLoS One 2026;21:e0357883.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zuo Z, Yang C, Hu L, Ye X, et al. Superior diagnostic efficacy and cost advantage of FibroTouch over CHI3L1 for liver fibrosis in Chinese patients with chronic liver disease. PLoS One 2026;21:e0357883.
PMID: 42832494